Variations in cancer survival and patterns of care across Europe: Roles of wealth and health-care organization

Journal of the National Cancer Institute - Monographs

Volumn , Issue 46, 2013, Pages 79-87

  Gatta, Gemma ^a   Trama, Annalisa ^a   Capocaccia, Riccardo ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; EUROPE; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; ADOLESCENT; ADULT; AGED; BREAST TUMOR; COLORECTAL TUMOR; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; ORGANIZATION AND MANAGEMENT; PROSTATE TUMOR; SOCIOECONOMICS; STATISTICS; SURVIVAL; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; EPIDEMIOLOGY; NEOPLASMS; PROSTATIC NEOPLASMS; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DELIVERY OF HEALTH CARE; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSTATIC NEOPLASMS; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84882938545     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgt004     Document Type: Article

References (49)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [database online]. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr. Accessed April 12, 2012.
2. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8(9):784-796.
3. Micheli A, Coebergh JW, Mugno E, et al. European health system and cancer care. Annals of Oncology. 2003;14(5):v41-v60.
4. Micheli A, Gatta G, Verdecchia A. Studying survival of cancer patients in different populations: its potential and role. Tumori. 1997;83(1):3-8.
5. Micheli A, Capocaccia R, Martinez C, et al. Cancer control in Europe. A proposed set of European Cancer Health Indicators. Eur J Public Health. 2003;13(3):116-118.
6. Kogevinas M, Pearce N, Susser M, Boffetta P. Social Inequalities and Cancer. Lyon, France: International Agency for Research on Cancer (IARC); 1997. IARC Scientific Publication No.138.
7. Organisation for Economic Co-operation and Development (OECD). Health at a Glance: OECD Indicators 2005. Paris, France: OECD; 2005.
8. Organisation for Economic Co-operation and Development. OECD Health Data 2011. http://www.oecd.org/document/16/0,3746,en_2649_33929_2085200_1_1_1_1,00.html. Accessed April 18, 2012.
9. Bentzen SM, Heeren G, Cottier B, et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol. 2005;75(3):355-365.
10. Busse R. Health Care System in Europe-An Impossible Overview. http://www.mig.tu-berlin.de/fileadmin/a38331600/2004.lectures/Berlin_2004.01.18.rb_AWS.pdf. Accessed April 12, 2012.
11. European Observatory on Health Systems and Policies Web site. http://www.euro.who.int/en/who-we-are/partners/observatory. Accessed April 30, 2012.
12. Allemani C, Storm H, Voogd AC, et al. Variation in "standard care" for breast cancer across Europe: a EUROCARE-3 high resolution study. Eur J Cancer. 2010;46(9):1528-1536.
13. Gatta G, Zigon G, Aareleid T, et al. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study. Acta Oncol. 2010;49(6):776-783.
14. Gatta G, Zigon G, Buemi A, et al. Prostate cancer treatment in Europe at the end of 1990s. Acta Oncol. 2009;48(6):867-873.
15. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer. 2009;45(6):931-991.
16. Miller DC, Gruber SB, Hollenbeck BK, Montie JE, Wei JT. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst. 2006;98(16):1134-1141.
17. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730-756.
18. Allemani C, Sant M, Weir HK, et al. Breast cancer survival in the US and Europe: a CONCORD high-resolution study [published online ahead of print September 18, 2012]. Int J Cancer. 2013;132(5):1170-1181. doi:10.1002/ijc.27725.
19. Verdecchia A, Guzzinati S, Francisci S, et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer. 2009;45(6):1042-1066.
20. Blanpain J, Young ME, Gunji A, Scheiber G. Health care in the EC member states. Health Policy. 1992;20(1-2):1-251.
21. WagstaffA, Van Doorslaer E. Equity in the finance and delivery of health care: concepts and definitions. In: Van Doorslaer, E, WagstaffA, Rutten F, eds. Equity and the Finance and Delivery of Health Care: An International Perspective. Oxford, UK: Oxford University Press; 1993:8-19.
22. Organisation for Economic Co-operation and Development. The Reform of Health Care: A Comparative Analysis of Seven OECD Countries. Paris, France: OECD; 1992.
23. Elola J, Daponte A, Navarro V. Health indicators and the organization of health care systems in Western Europe. Am J Public Health. 1995;85(10):1397-1401.
24. Organisation for Economic Co-operation and Development. OECD Health Systems: Facts and Trends. Paris, France: OECD; 1993.
25. Abel-Smith B. Cost containment and new priorities in the European community. Milbank Q. 1992;70(3):393-416.
26. Evans RG. Public health insurance: the collective purchase of individual care. Health Policy. 1987;7(29):175-188.
27. Jonsson B. What can Americans learn from Europeans? Health Care Financ Rev. 1989;Suppl:79-93.
28. Poullier J-P. Administrative costs in selected industrialized countries. Health Care Financ Rev. 1992;13(4):167-172.
29. Bartelink H, Garavaglia G, Johansson KA, et al. Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology). Radiother Oncol. 1991;22(4):323-326.
30. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305(1):6-11.
31. Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991;9(6):1059-1070.
32. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328(22):1587-1591.
33. Fisher B, Bauer M, Margolese R. Five year results of a randomised clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312(11):665-673.
34. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320(13):822-828.
35. Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial. Cancer. 1977;39(6):2827-2839.
36. Stanford Health Services. Update of the NCCN guidelines for treatment of breast cancer. Oncology. 1997;11(11A):199-220.
37. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 1998;352(9132):930-942.
38. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989;7(10):1447-1556.
39. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma. N Engl J Med. 1990;322(6):352-358.
40. Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20(11):2643-2650.
41. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet. 1992;339(8784):1-15.
42. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20(5):1192-1202.
43. Taal BG, Van Tinteren H, Zoetmulder FA; the NACCP Group. Adjuvant 5FU plus levamisole in colonic or rectal cancer: Improved survival in stage II and III. Br J Cancer. 2001;85(10):1437-1443.
44. Glimelius B, Dahl O, Cedermark B, et al. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol. 2005;44(8):904-912.
45. Dahl O, Fluge O, Carlsen E, et al. Final results of a randomised phase III study on adjuvant chemotherapy with 5FU and levamisole in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncol. 2009;48(3):368-376.
46. von Karsa L, Anttila A, Ronco G, et al. Cancer Screening in the European Union: Report on the Implementation of the Council Recommendation on Cancer Screening - First Report. Luxembourg: European Communities; 2008.
47. NCCN Guidelines for Treatment of Cancer by Site: Prostate Cancer Version 3. 2012. National Comprehensive Cancer Network (NCCN) Web site. http://www.nccn.org/professionals/physician_gls/f_guidelines. asp#site. Accessed June 11, 2012.
48. Coleman MP, Alexe D-M, Albrecht T, McKee M, eds. Responding to the Challenge of Cancer in Europe. Ljubljana, Slovenia: Institute of Public Health of the Republic of Slovenia; 2008.
49. European Partnership for Action Against Cancer Web site. http://www.epaac.eu/. Accessed June 11, 2012.